Citation Impact
Citing Papers
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Immune Rejection of Mouse Tumors Expressing Mutated Self
2009 StandoutNobel
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
2015
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Rapid generation of a mouse model for Middle East respiratory syndrome
2014
Exploiting the Mutanome for Tumor Vaccination
2012
NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
2017
Deep learning pan‐specific model for interpretable MHC‐I peptide binding prediction with improved attention mechanism
2021
Anti‐LGI1 encephalitis is associated with unique HLA subtypes
2016
Five HLA-DP Molecules Frequently Expressed in the Worldwide Human Population Share a Common HLA Supertypic Binding Specificity
2010
An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model
2017
High sensitivity of cancer exome-based CD8 T cell neo-antigen identification
2014
A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach
2008
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
HLA class I supertypes: a revised and updated classification
2008
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Accurate Prediction of Peptide Binding Sites on Protein Surfaces
2009
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
2017
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Elevated Pre–Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection
2017 StandoutNobel
Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
2008
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
The Principal Genetic Determinants for Nasopharyngeal Carcinoma in China Involve the HLA Class I Antigen Recognition Groove
2012
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
2013
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
2014 Nature
pDOCK: a new technique for rapid and accurate docking of peptide ligands to Major Histocompatibility Complexes
2010
Computational genomics tools for dissecting tumour–immune cell interactions
2016
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Properties of MHC Class I Presented Peptides That Enhance Immunogenicity
2013
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
2015
Peptide binding predictions for HLA DR, DP and DQ molecules
2010
Sources of diversity in T cell epitope discovery
2011
Clinical and immunological features of severe and moderate coronavirus disease 2019
2020 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
2014
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Nasopharyngeal carcinoma
2015 Standout
Graft-versus-host disease
2009 Standout
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
MHC Class II epitope predictive algorithms
2010
Molecules and mechanisms of the graft-versus-leukaemia effect
2004
NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure
2010
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Predicting HLA CD4 Immunogenicity in Human Populations
2018
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
HLA class II amino acid epitopes as susceptibility markers of sarcoidosis
2007
Computationally Designed Armadillo Repeat Proteins for Modular Peptide Recognition
2016 StandoutNobel
Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside
2014
Fully human CD19-specific chimeric antigen receptors for T-cell therapy
2017
Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes
2011
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
2017 Standout
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Structural Prediction of Peptide–MHC Binding Modes
2022
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
2017
Sarcoidosis
2007 Standout
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
2006 Standout
Antibody-Mediated Encephalitis
2018 Standout
MHCAttnNet: predicting MHC-peptide bindings for MHC alleles classes I and II using an attention-based deep neural model
2020
Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data
2020
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
DeepLigand: accurate prediction of MHC class I ligands using peptide embedding
2019
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
2013
Large-scale characterization of peptide-MHC binding landscapes with structural simulations
2011
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Peptide-binding specificity prediction using fine-tuned protein structure prediction networks
2023 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Chimeric Antigen Receptor Therapy
2018 Standout
Epitope Landscape in Breast and Colorectal Cancer
2008 StandoutNobel
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
Cancer Genome Landscapes
2013 StandoutScience
Automatic Generation of Validated Specific Epitope Sets
2015
The MHC class I peptide repertoire is molded by the transcriptome
2008
Neoantigens in cancer immunotherapy
2015 StandoutScience
Divergent Motifs but Overlapping Binding Repertoires of Six HLA-DQ Molecules Frequently Expressed in the Worldwide Human Population
2010
TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates
2016
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells
2016
Chemokines in Innate and Adaptive Host Defense : Basic Chemokinese Grammar for Immune Cells
2004
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Works of Kasper Lamberth being referenced
SARS CTL vaccine candidates; HLA supertype‐, genome‐wide scanning and biochemical validation
2004
Peptide Binding to HLA Class I Molecules: Homogenous, High-Throughput Screening, and Affinity Assays
2009
One-Pot, Mix-and-Read Peptide-MHC Tetramers
2008
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
2009
Identification of CD8+ T Cell Epitopes in the West Nile Virus Polyprotein by Reverse-Immunology Using NetCTL
2010
Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction
2007
CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening
2006
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays
2009
Human Leukocyte Antigen (HLA) Class I Restricted Epitope Discovery in Yellow Fewer and Dengue Viruses: Importance of HLA Binding Strength
2011
Reliable prediction of T‐cell epitopes using neural networks with novel sequence representations
2003
NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence
2007
NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11
2008
Definition of supertypes for HLA molecules using clustering of specificity matrices
2004
Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach
2004
An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions
2005
The peptide-binding specificity of HLA-A*3001 demonstrates membership of the HLA-A3 supertype
2008
Establishment of a quantitative ELISA capable of determining peptide – MHC class I interaction
2002
A Community Resource Benchmarking Predictions of Peptide Binding to MHC-I Molecules
2006
SARS CTL Vaccine Candidates — HLA Supertype, Genome‐Wide Scanning and Biochemical Validation
2004
CCR3 Expression Induced by IL-2 and IL-4 Functioning as a Death Receptor for B Cells
2003